Research Ties PPIs with Pancreatic Cancer, Death
Parker Waichman LLP is investigating potential lawsuits on behalf of individuals who were diagnosed with pancreatic cancer or who died following treatment with a proton pump inhibitor. What Are PPIs? According to MedicineNet, proton pump inhibitors are used in the prevention and treatment of acid-related conditions such as … [Read more...] about Research Ties PPIs with Pancreatic Cancer, Death
Link Found Between Red Meat and Pancreatic Cancer
Red Meat May Increase The Risk Of Cancer. Eating a diet high in red and processed meats may increase the risk of pancreatic cancer by an alarming degree. A new study in the Journal of the National Cancer Institute found that people who ate high amounts of processed meats, such as luncheon meat and sausage, had a 68% higher risk of … [Read more...] about Link Found Between Red Meat and Pancreatic Cancer
Pancreatitis, Pancreatic and Thyroid Cancer Associated with Januvia
Januvia May Increased Cancer Risks. Our firm is investigating potential lawsuits on behalf of patients who suffered from pancreatitis, pancreatic cancer or thyroid cancer related to the use of glucagon-like peptide-1-based therapies such as Januvia (sitagliptin). Januvia is a prescription medicine used along with diet and exercise to … [Read more...] about Pancreatitis, Pancreatic and Thyroid Cancer Associated with Januvia
Victoza Side Effects Lawsuits
Victoza Side Effect Injury Lawsuits. Our firm is investigating potential lawsuits on behalf of patients who suffered from pancreatitis, pancreatic cancer, kidney failure or thyroid cancer related to the use of Victoza (liraglutide), a Type 2 diabetes medication. Denmark-based manufacturer Novo Nordisk gained approval for … [Read more...] about Victoza Side Effects Lawsuits
Tradjenta Lawsuits
Tradjenta Risk of Pancreatic Cancer. Tradjenta (linagliptin) is a type 2 diabetes medication developed by Eli Lilly and Boehringer Ingelheim; it belongs to a class of diabetes drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. Tradjenta was approved by the U.S. Food and Drug Administration (FDA) in May 2011. It is … [Read more...] about Tradjenta Lawsuits
Onglyza Associated with Pancreatitis, Pancreatic Cancer, and Cardiac Issues
The Type 2 diabetes medication, Onglyza (saxagliptin), is often offered as a preferred option for diabetics, along with a healthy lifestyle, including exercise and diet; however, Onglyza has been associated with increased risks for pancreatic cancer and heart issues. Approved in 2009, Onglyza was released as a collaboration … [Read more...] about Onglyza Associated with Pancreatitis, Pancreatic Cancer, and Cardiac Issues
Onglyza Serious Side Effects
Litigation Over Kombiglyze XR and Onglyza. Potential Lawsuits Over Onglyza and Kombiglyze XR Drugs. Personal injury attorneys are investigating potential lawsuits over Onglyza and Kombiglyze XR, diabetes medications containing saxagliptin. Drug injury lawyers are reviewing whether or not they can pursue litigation over Kombiglyze … [Read more...] about Onglyza Serious Side Effects
Arkansas Man Claims Byetta Caused Pancreatic Cancer
Complications Developed After Using Byetta. An Arkansas man claims that taking the type 2 diabetes drug Byetta caused him to develop pancreatic cancer. After developing pancreatic cancer and beginning chemotherapy and radiation therapies, the man also developed jaundice. His lawsuit against Amylin Pharmaceuticals Inc. and Eli … [Read more...] about Arkansas Man Claims Byetta Caused Pancreatic Cancer
Byetta, Victoza Raise More Cancer Fears
Byetta Increased The Risk Of Pancreatic Cancer. A new study is adding to concerns that type 2 drugs like Byetta and Victoza could increase the likelihood that a patient will develop pancreatitis and pancreatic cancer. The study found that Byetta increases the risk for pancreatitis - a known risk factor for pancreatic cancer … [Read more...] about Byetta, Victoza Raise More Cancer Fears
Health Canada on Tarceva Complications
Health Canada Warns on Tarceva Complications. Lung and pancreatic cancer drug, Tarceva (erlotinib), continues to be linked to serious, sometimes fatal, adverse reactions. According to two separate releases from Hoffman La-Roche, the maker of Tarceva in Europe, the drug has been associated with cases of gastrointestinal perforation, … [Read more...] about Health Canada on Tarceva Complications
Researchers Develop Testing Procedure for Pancreatic Cancer
New Study Of Identifying Families At High Risk Of Pancreatic Cancer. A new study by scientists at the University of Liverpool suggests there may be a way of identifying families at high risk of pancreatic cancer. The Liverpool research group called EUROPAC (European Registry Of Hereditary Pancreatitis And Familial Pancreatic … [Read more...] about Researchers Develop Testing Procedure for Pancreatic Cancer
